Data as of Aug 29
| +0.28 / +1.25%|
The 5 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 22.00, with a high estimate of 28.00 and a low estimate of 21.00. The median estimate represents a -2.78% decrease from the last price of 22.63.
The current consensus among 5 polled investment analysts is to Hold stock in AMAG Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.